822 related articles for article (PubMed ID: 11805567)
1. Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance study.
Lindberg BU; Broomé U; Persson B
Dis Colon Rectum; 2001 Jan; 44(1):77-85. PubMed ID: 11805567
[TBL] [Abstract][Full Text] [Related]
2. Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.
Tung BY; Emond MJ; Haggitt RC; Bronner MP; Kimmey MB; Kowdley KV; Brentnall TA
Ann Intern Med; 2001 Jan; 134(2):89-95. PubMed ID: 11177311
[TBL] [Abstract][Full Text] [Related]
3. Colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.
Gurbuz AK; Giardiello FM; Bayless TM
Dis Colon Rectum; 1995 Jan; 38(1):37-41. PubMed ID: 7813342
[TBL] [Abstract][Full Text] [Related]
4. Dysplasia and colorectal cancer in a patient with ulcerative colitis and primary sclerosing cholangitis: a case report and a short review of the literature.
Chaparro M; Trapero-Marugán M; Guijarro M; López C; Moreno-Otero R; Gisbert JP
J Crohns Colitis; 2013 Mar; 7(2):e61-5. PubMed ID: 22552273
[TBL] [Abstract][Full Text] [Related]
5. Random biopsies during surveillance colonoscopy increase dysplasia detection in patients with primary sclerosing cholangitis and ulcerative colitis.
Navaneethan U; Kochhar G; Venkatesh PG; Bennett AE; Rizk M; Shen B; Kiran RP
J Crohns Colitis; 2013 Dec; 7(12):974-81. PubMed ID: 23523416
[TBL] [Abstract][Full Text] [Related]
6. The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis.
Wolf JM; Rybicki LA; Lashner BA
Aliment Pharmacol Ther; 2005 Nov; 22(9):783-8. PubMed ID: 16225486
[TBL] [Abstract][Full Text] [Related]
7. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
Venkatesh PG; Jegadeesan R; Gutierrez NG; Sanaka MR; Navaneethan U
J Crohns Colitis; 2013 Dec; 7(12):968-73. PubMed ID: 23433613
[TBL] [Abstract][Full Text] [Related]
8. Liver involvement in patients operated for ulcerative colitis, with special reference to the association of cholangitis with colorectal dysplasia and carcinoma.
Aitola P; Mattila J; Matikainen M
Int J Colorectal Dis; 2000 Jun; 15(3):167-71. PubMed ID: 10954188
[TBL] [Abstract][Full Text] [Related]
9. Increased risk of colorectal cancer and dysplasia in patients with Crohn's colitis and primary sclerosing cholangitis.
Lindström L; Lapidus A; Ost A; Bergquist A
Dis Colon Rectum; 2011 Nov; 54(11):1392-7. PubMed ID: 21979184
[TBL] [Abstract][Full Text] [Related]
10. [Colorectal cancer in ulcerative colitis].
Laugesen KB; Tøttrup A
Ugeskr Laeger; 2014 Jan; 176(4A):V07130441. PubMed ID: 25347248
[TBL] [Abstract][Full Text] [Related]
11. Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential.
Broomé U; Löfberg R; Veress B; Eriksson LS
Hepatology; 1995 Nov; 22(5):1404-8. PubMed ID: 7590655
[TBL] [Abstract][Full Text] [Related]
12. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis.
Soetikno RM; Lin OS; Heidenreich PA; Young HS; Blackstone MO
Gastrointest Endosc; 2002 Jul; 56(1):48-54. PubMed ID: 12085034
[TBL] [Abstract][Full Text] [Related]
13. Surgical management of ulcerative colitis in the presence of primary sclerosing cholangitis.
Poritz LS; Koltun WA
Dis Colon Rectum; 2003 Feb; 46(2):173-8. PubMed ID: 12576890
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric and histologic evaluation in a large cohort of patients with ulcerative colitis: correlation with clinical characteristics and impact on surveillance.
Holzmann K; Klump B; Borchard F; Gregor M; Porschen R
Dis Colon Rectum; 2001 Oct; 44(10):1446-55. PubMed ID: 11598473
[TBL] [Abstract][Full Text] [Related]
15. Population-based analysis of practices and costs of surveillance for colonic dysplasia in patients with primary sclerosing cholangitis and colitis.
Kaplan GG; Heitman SJ; Hilsden RJ; Urbanski S; Myers RP; Lee SS; Burak KW; Swain M; Panaccione R
Inflamm Bowel Dis; 2007 Nov; 13(11):1401-7. PubMed ID: 17600816
[TBL] [Abstract][Full Text] [Related]
16. Risk for colorectal neoplasia in patients with colonic Crohn's disease and concomitant primary sclerosing cholangitis.
Braden B; Halliday J; Aryasingha S; Sharifi Y; Checchin D; Warren BF; Kitiyakara T; Travis SP; Chapman RW
Clin Gastroenterol Hepatol; 2012 Mar; 10(3):303-8. PubMed ID: 22037429
[TBL] [Abstract][Full Text] [Related]
17. [Recent Advances in Understanding Colorectal Cancer and Dysplasia Related to Ulcerative Colitis].
Yang DH
Korean J Gastroenterol; 2015 Dec; 66(6):312-9. PubMed ID: 26691188
[TBL] [Abstract][Full Text] [Related]
18. Colorectal cancer and dysplasia risk of ulcerative colitis patients in a tertiary referral center in Turkey.
Ünal NG; Özütemiz Ö; Tekin F; Turan İ; Osmanoğlu N
Turk J Gastroenterol; 2019 Feb; 30(2):139-147. PubMed ID: 30460897
[TBL] [Abstract][Full Text] [Related]
19. Risk of Colon Cancer and Recommended Surveillance Strategies in Patients with Ulcerative Colitis.
Rabbenou W; Ullman TA
Gastroenterol Clin North Am; 2020 Dec; 49(4):791-807. PubMed ID: 33121696
[TBL] [Abstract][Full Text] [Related]
20. Early progression to high-grade dysplasia in a patient with ulcerative colitis and primary sclerosing cholangitis.
Mahady SE; Connell WR; Keck JO; Bell S
Intern Med J; 2005 Dec; 35(12):730-1. PubMed ID: 16313551
[No Abstract] [Full Text] [Related]
[Next] [New Search]
